Five-Year Patterns of Diabetic Retinopathy Progression in US Clinical Practice
Andrew Moshfeghi,1 Vincent Garmo,2 Daniel Sheinson,2 Avanti Ghanekar,2 Ibrahim Abbass2 1USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; 2Genentech, Inc., South San Francisco, CA, USACorrespondence: Andrew Moshfeg...
Guardado en:
Autores principales: | Moshfeghi A, Garmo V, Sheinson D, Ghanekar A, Abbass I |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/52d5e5e6202f4c0a9e6704b5df17d47e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Macular oedema as manifestation of diabetic retinopathy
por: Mukharram M. Bikbov, et al.
Publicado: (2017) -
Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
por: Kartasasmita A, et al.
Publicado: (2019) -
Photobiomodulation Therapy for Age-Related Macular Degeneration and Diabetic Retinopathy: A Review
por: Muste JC, et al.
Publicado: (2021) -
Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema
por: Varma R, et al.
Publicado: (2020) -
Biomarkers for diabetic retinopathy
por: Maria V. Budzinskaya, et al.
Publicado: (2020)